obesity

House committee backs some Medicare cover for obesity drugs
Pharmaphorum
Fri, 06/28/24 - 11:13 am
legislation
Medicare
obesity
Wegovy
Zepbound
Zealand Pharma brings in $1B to drive development of obesity drugs
First Word Pharma
Wed, 06/26/24 - 10:04 am
Zealand Pharma
obesity
funding
Pfizer's Working on the Next Wegovy, but Can It Beat Novo Nordisk?
Motley Fool
Tue, 06/25/24 - 11:17 am
Pfizer
Novo Nordisk
obesity
Ozempic
ProFound Therapeutics
Altimmune Targets Obesity Market With Weight-Loss Drug That Preserves Lean Muscle Mass
BioSpace
Mon, 06/24/24 - 10:18 pm
Altimmune
pemvidutide
weight loss
clinical trials
obesity
Obesity drug from Zealand shows potential in early trial
BioPharma Dive
Thu, 06/20/24 - 05:57 pm
Zealand Pharma
obesity
clinical trials
petrelintide
Sanders hopes pressure will force down Ozempic price
Axios
Thu, 06/20/24 - 11:23 am
Novo Nordisk
drug pricing
Ozempic
obesity
Bernie Sanders
Could Structure Therapeutics Become the Next Novo Nordisk?
Motley Fool
Mon, 06/17/24 - 11:38 am
Structure Therapeutics
weight loss
Novo Nordisk
obesity
GS-1290
GLP-1 global obesity market to reach $111B by 2033, despite headwinds: GlobalData
BioSpace
Fri, 06/14/24 - 11:48 am
GLP-1 agonists
Novo Nordisk
Eli Lilly
obesity
weight loss
Employer coverage for weight-loss drugs rises sharply, survey finds
Reuters
Thu, 06/13/24 - 11:05 pm
insurance
weight loss
obesity
Eli Lilly
Novo Nordisk
Wegovy
Zepbound
Palatin Technologies commences Phase II study of obesity treatment
Clinical Trials Arena
Thu, 06/13/24 - 11:03 am
Palatin
clinical trials
breatelanotide
obesity
Pfizer, Flagship name first target for multibillion-dollar collaboration: obesity
Fierce Biotech
Wed, 06/12/24 - 11:16 am
Pfizer
Flagship Pioneering
ProFound Therapeutics
obesity
drug development
Syntis Bio Launches in Effort to Challenge GLP-1s in Lucrative Weight Loss Market
BioSpace
Tue, 06/11/24 - 11:27 am
Syntis Bio
obesity
weight loss
SYNT-101
Eli Lilly exec says seeing out of pocket payments for obesity drug in US
Reuters
Mon, 06/10/24 - 06:06 pm
Eli Lilly
Zepbound
Mounjaro
patients
obesity
diabetes
Novo Nordisk launches campaign for injectable weight-loss drug Wegovy
Medical Marketing and Media
Tue, 06/4/24 - 11:48 am
Novo Nordisk
Wegovy
weight loss
obesity
DTC advertising
Lilly wins NICE endorsement for tirzepatide in obesity—with a catch
Fierce Pharma
Tue, 06/4/24 - 11:38 am
Eli Lilly
UK
NICE
tirzepatide
obesity
type 2 diabetes
diabetes
Structure Therapeutics pill leads to competitive weight loss in obesity study
BioPharma Dive
Mon, 06/3/24 - 10:26 pm
Structure Therapeutics
obesity
weight loss
GSBR-1290
Weight loss drugs are so hard to find that this company built a tracker
Axios
Thu, 05/30/24 - 11:09 pm
Novo Nordisk
Eli Lilly
Wegovy
Zepbound
weight loss
obesity
drug shortages
Ro
CinCor’s ‘hub-and-spoke’ parent nabs new funding to build its next biotechs
BioPharma Dive
Thu, 05/30/24 - 11:10 am
CinRx Pharma
funding
obesity
IBS
gastroparesis
America's doctors need more obesity medicine training
Axios
Tue, 05/28/24 - 10:49 am
physicians
obesity
GLP-1 agonist
Wegovy
Wegovy users have fewer kidney-related health problems, analysis of Novo study finds
Reuters
Sun, 05/26/24 - 12:29 pm
Novo Nordisk
obesity
Wegovy

Pages